About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


22 Rich. J.L. & Tech. 1 (2015-2016)

handle is hein.journals/jolt22 and id is 1 raw text is: Richmond Journal of Law & Technology CAN I CALL You BACK? A SUSTAINED INTERACTION WITH BIOSPECIMEN DONORS TO FACILITATE ADVANCES IN RESEARCH Jonathan S. Miller Cite as: Jonathan Miller, Can I Call You Back? A Sustained Interaction with Biospecimen Donors to Facilitate Advances in Research, 22 RICH. J.L. & TECH. 1 (2015), http://jolt.richmond.edu/v22i1/article1.pdf I. INTRODUCTION [1] For the cure. This statement resonates throughout society and offers a simple reasoning for the conduct of biomedical research. It provides a strong impetus for advocates of biomedical research to pursue appropriations to support research hypotheses, advanced medical technologies, and targeted therapeutic strategies. Answering sophisticated medical questions, however, requires researchers and clinicians to have an adequate supply of materials necessary to facilitate their research endeavors. These materials-commonly referred to as biospecimens- may include frozen human embryos, tissue specimens, blood samples, buccal swabs, or exhaled breath condensate, all of which may be collected and stored in biobanks.1 [2] The use of human embryos for research purposes generated national attention on March 9, 2009, following the release of Executive Order (E.O.) 13505, titled Removing Barriers to Responsible Scientific Research Involving Human Stem Cells.2 E.O. 13505 recognized that 1 See Biobanking, COLLINS DICTIONARY, http://www.collinsdictionary.com/dictionary/english/biobanking, archived at http://perma.cc/WQU4-Q5GD (last visited Oct. 9, 2015) (defining biobanking as the practice of creating large-scale repositories of human biological material (e.g. blood, urine, tissue samples, DNA, etc.) designed to further medical research). 1 Volume XXII, Issue I